Skip to content
Erythromycin
Active ingredient: Erythromycin

Erythromycin

Quality products
24/7 Support
Fast delivery
Delivery from 4 days
Select pack Package Per unit Price

Free delivery on orders from AED 796.00, free express delivery from AED 1,194.00

Secure Payments
Track your order
Best price guarantee

Use depends on the infection. A clinician sets the dose and schedule.

About this product

Erythromycin is a macrolide antibiotic. It treats susceptible bacterial infections. It limits bacterial protein production.

Pharmacological action

Erythromycin belongs to the macrolide antibiotic class. It acts mainly by binding to the 50S subunit of the bacterial ribosome, which interrupts protein synthesis required for bacterial growth. The effect is usually bacteriostatic, although higher concentrations may kill susceptible organisms.

The oral route allows the active substance to reach tissues through the bloodstream. This differs from a skin-applied preparation, which delivers medicine mainly to the treated surface. Erythromycin pills are therefore intended for systemic treatment when oral antibiotic therapy is clinically appropriate.

The FDA prescribing information describes erythromycin as an antibacterial drug whose use should reflect the sensitivity of the infecting organism [1].

What it contains

Erythromycin is the active antibacterial substance in this product. The product is supplied as pills, so the medicine is taken by mouth rather than applied to the skin. The exact strength selected for treatment depends on the infection, age, body weight, organ function, and the dosage plan agreed with a doctor or pharmacist.

The macrolide class includes antibiotics that interfere with bacterial ribosomes. Human cells do not use the same bacterial ribosomal structure, which gives erythromycin its selective antibacterial action. This mechanism does not make the medicine suitable for every infection because bacteria can develop resistance or may naturally be unaffected.

The formulation can influence tolerability and absorption. Some erythromycin products are affected by stomach acidity, while others are designed to resist acid degradation. This is one reason the product-specific dosing instructions matter.

Do not crush, split, or chew a pill unless the prescribed product is designed for that use. Altering a modified-release or specially coated formulation can change how erythromycin is released.

Directions for use

The dose and frequency depend on the purpose of use and are agreed with a doctor or pharmacist. Treatment length also varies with the infection. A bacterial infection may require a different schedule from another infection, even when the same antibiotic is used.

Practical administration principles include:

  • swallow the pills by mouth with water;
  • use the prescribed interval between doses;
  • take each dose at the same times each day when possible;
  • follow the food instructions given for the specific erythromycin formulation;
  • complete the prescribed course unless a clinician changes it;
  • do not double the next dose after a missed dose;
  • if a missed dose is remembered close to the next scheduled dose, skip the missed dose and resume the usual schedule.

A missed dose usually does not justify taking two doses together. Double dosing can increase nausea, abdominal pain, and other adverse effects without improving antibacterial activity.

Keep a simple dose record when treatment involves several daily doses. People commonly remember the morning tablet and then lose track after a busy afternoon.

Do not share erythromycin with another person. The same symptoms can arise from different conditions, and the bacteria may not be susceptible to the same antibiotic.

Reasons not to use it

Erythromycin is not suitable for everyone. The medicine may be inappropriate when a person has a serious previous reaction to erythromycin or another macrolide, certain heart-rhythm disorders, or severe liver disease.

  • a serious previous reaction to erythromycin or another macrolide;
  • a known prolonged QT interval or a serious ventricular rhythm disorder;
  • active severe liver impairment unless a specialist has specifically judged treatment appropriate;
  • a medicine that has a dangerous interaction with erythromycin;
  • a viral illness with no evidence of a susceptible bacterial infection.

Erythromycin inhibits intestinal and hepatic drug-metabolising pathways, including CYP3A4. This can raise concentrations of medicines such as certain statins, anticoagulants, anticonvulsants, sedatives, and immunosuppressants. It may also interact with anti-arrhythmic medicines and other drugs that prolong the QT interval.

Specific combinations require review before the first dose. Examples include simvastatin or lovastatin, some ergot medicines, pimozide, cisapride where still used, and selected anti-arrhythmic agents. The FDA label lists serious interaction risks and cardiac precautions for erythromycin .

Warfarin may require closer monitoring because an antibiotic can alter anticoagulant response. Digoxin concentrations may also rise in some patients. Grapefruit products can affect medicines metabolised through similar pathways, so the prescriber should receive a complete list of foods, supplements, and medicines used regularly.

When this is not for you

This medication is not for you if:

  • you previously developed a severe allergic reaction to erythromycin or a related macrolide;
  • you have a known prolonged QT interval or a serious ventricular rhythm disorder;
  • you have active severe liver impairment unless a specialist has specifically judged treatment appropriate;
  • you take a medicine that has a dangerous interaction with erythromycin;
  • the illness is viral and there is no evidence of a susceptible bacterial infection.

Adverse reactions

Erythromycin can cause digestive symptoms, including nausea, abdominal discomfort, vomiting, and diarrhoea. These effects may occur because macrolides influence gastrointestinal motility as well as bacterial activity. Taking the medicine exactly as directed can reduce avoidable dosing errors, although it cannot prevent every adverse effect.

Other possible reactions include:

  • reduced appetite;
  • headache;
  • temporary changes in taste;
  • skin rash or itching;
  • abnormal liver enzyme results;
  • oral or vaginal overgrowth of organisms such as Candida after antibiotic exposure.

Most mild digestive symptoms are self-limited, but persistent or severe diarrhoea needs prompt medical attention. Antibiotic-associated colitis can occur during treatment or after it has finished. Watery or bloody stools, marked abdominal cramping, or fever require urgent assessment.

Erythromycin can also prolong the QT interval, an electrical measurement on the heart tracing. This may raise the risk of an abnormal rhythm in susceptible people. The risk is greater with a previous prolonged QT interval, low potassium or magnesium, significant heart disease, or other medicines that affect cardiac rhythm.

Tell the prescriber about fainting, unexplained palpitations, or a known rhythm disorder before treatment. Those details can change the choice of antibiotic.

Liver injury is uncommon but clinically significant. Yellowing of the skin or eyes, dark urine, unusually pale stools, severe itching, or persistent upper abdominal discomfort should be assessed promptly.

Uses

Erythromycin may be selected for susceptible infections involving the respiratory tract, skin, soft tissues, or other sites. It can also be used when a patient cannot take a penicillin-type antibiotic, provided erythromycin is suitable for the organism and the patient’s medical history.

A clinician may consider:

  • the likely or confirmed bacterium;
  • antibiotic resistance in the relevant region;
  • the infection site and severity;
  • liver function and other medical conditions;
  • previous reactions to macrolide antibiotics;
  • other medicines that may interact with erythromycin;
  • the patient’s age, pregnancy status, and ability to swallow pills.

The WHO and the UK Medicines and Healthcare products Regulatory Agency (MHRA) promote responsible antibiotic selection because unnecessary exposure increases antimicrobial resistance. Erythromycin should therefore be reserved for infections where its antibacterial activity is expected to provide clinical benefit [2].

Comparison

Erythromycin pills provide systemic exposure. Other antibiotic approaches may be local or may use a different antibacterial class, depending on the infection and susceptibility results.

Approach Main role Main limitation
Oral erythromycin Treats selected susceptible bacterial infections through systemic exposure Gastrointestinal effects, interactions, and resistance can limit use
Local antibiotic treatment Targets a limited skin or surface infection May be inadequate for deeper or systemic infection
Non-macrolide antibiotic Used when the organism or patient factors favour another class Choice depends on allergy history, resistance, and organ function

Erythromycin is not automatically the first choice for every bacterial illness. A different antibiotic may be preferred when resistance is likely, when a serious interaction is present, or when another class offers more reliable activity against the suspected organism.

For acne and other local skin conditions, oral antibiotics are generally reserved for situations where local care is insufficient or the disease is more extensive. NICE guidance recommends limiting antibiotic exposure and avoiding antibiotic-only approaches that can encourage resistance [3].

Common mistakes

Several practical errors can reduce treatment success or increase adverse effects:

  • taking doses only when symptoms feel severe;
  • stopping as soon as fever or pain improves;
  • doubling a dose after forgetting one;
  • using leftover pills for a later illness;
  • failing to mention medicines for cholesterol, heart rhythm, seizures, or blood clot prevention;
  • taking erythromycin despite a previous serious macrolide reaction;
  • treating severe diarrhoea with self-selected medication;
  • assuming that a rash is harmless when it is spreading or accompanied by facial swelling;
  • crushing a coated pill without confirming that the formulation permits it.

One real-world problem is incomplete medication history. Patients may mention tablets but forget inhalers, herbal products, or occasional sleep medicines. Erythromycin interactions can involve medicines taken only once or twice weekly.

Keep the full medicine list together, including non-daily treatments and supplements. Erythromycin interaction screening depends on the complete list, not only on daily prescriptions.

Alcohol is not the defining interaction for erythromycin, but it can worsen nausea, dizziness, and poor judgement about missed doses. Avoiding alcohol during an antibiotic course may make it easier to recognise treatment-related symptoms.

What doctors say

In clinical practice, doctors often treat erythromycin as a targeted option rather than a universal antibiotic. The decision depends on the suspected pathogen, the infection site, resistance data, and the patient’s concurrent medicines.

A physician will usually want to know about:

  • previous antibiotic allergies;
  • heart rhythm problems or unexplained fainting;
  • liver disease;
  • pregnancy or breastfeeding;
  • anticoagulants and heart medicines;
  • statins, seizure medicines, and sedatives;
  • recent antibiotic courses.

Patients sometimes expect improvement after the first tablet. Symptoms may take time to settle because the medicine must reduce bacterial activity before inflammation resolves. A lack of improvement, worsening pain, breathing difficulty, persistent fever, or new confusion can indicate that the diagnosis or antibiotic choice needs reassessment.

A useful clinical distinction is between antibacterial effect and symptom relief. Erythromycin may control susceptible bacteria, but it does not instantly reverse swelling, tissue injury, or inflammation caused by the infection.

Questions and answers

Can older adults take Erythromycin?

Older adults can receive erythromycin when the expected benefit outweighs the risks. Age itself does not automatically prevent treatment, but liver function, heart rhythm, kidney status, and concurrent medicines need review. The FDA’s 2020 prescribing information supports careful assessment of QT-prolonging medicines and interaction risks. Older patients may also be more vulnerable to complications from diarrhoea, dehydration, or rhythm disturbances.

What should I do if the expected result does not come?

Do not increase the dose or extend treatment independently if symptoms do not improve. The infection may be caused by a resistant organism, may not be bacterial, or may require drainage or another treatment approach. NICE guidance updated in 2021 supports reassessment when an expected clinical response is absent, especially when symptoms worsen. Urgent assessment is needed for breathing difficulty, severe weakness, confusion, persistent high fever, or rapidly spreading infection.

Can people under 18 use Erythromycin?

Children and adolescents may receive erythromycin for selected infections, but the regimen is determined by age, body weight, infection type, and formulation. Adult dosing should not be transferred to a child without a paediatric prescription. WHO antibiotic guidance published in 2023 emphasises age-appropriate dosing and responsible antibiotic selection. A child who cannot swallow pills may require a different pharmaceutical form selected by a clinician.

Can Erythromycin be used during pregnancy or breastfeeding?

Erythromycin may be considered during pregnancy or breastfeeding when treatment is clinically indicated. The decision depends on the infection, timing of pregnancy, maternal health, and the specific formulation. The FDA’s 2020 prescribing information describes the need to balance maternal treatment needs with fetal or infant considerations. Breastfed infants should be observed for diarrhoea, rash, or feeding changes if the mother receives erythromycin.

How soon does the effect of Erythromycin become noticeable?

The timing varies with the infection and the amount of tissue inflammation present. Some symptoms may begin to improve within several days, while cough, skin inflammation, or tenderness can take longer to settle. FDA antibacterial prescribing information from 2020 states that the course should be completed as directed even when symptoms improve early. Worsening symptoms or no meaningful response during the prescribed course warrants clinical reassessment rather than extra tablets.

Can Erythromycin cause heart palpitations?

Erythromycin can affect cardiac electrical activity in susceptible people and may contribute to QT prolongation. The risk increases with certain heart medicines, low potassium or magnesium, liver disease, and a personal or family history of serious rhythm disorders. The FDA’s 2020 prescribing information identifies cardiac rhythm risk as a clinically relevant precaution for erythromycin. New palpitations, fainting, chest discomfort, or severe dizziness require urgent medical assessment.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.

Comparison

Compare treatments for Antibiotics

Sources

  1. U.S. Food and Drug Administration (2020). Erythromycin Tablets, USP — Prescribing Information.
  2. World Health Organization (2023). The WHO AWaRe Antibiotic Book: Antibiotic Treatment Guidance for Common Infections.
  3. National Institute for Health and Care Excellence (2021). Acne vulgaris: management, NICE guideline NG198.

Erythromycin: What Customers Say

3.3
Based on 3 reviews
Aisha, 33 Dubai Marina Several days
Verified
Rating: 3.5 out of 5

The stomach upset started after the second day and was annoying after meals. The infection symptoms improved before the course ended, so I kept taking it as prescribed rather than stopping early.

28 Oct 2026
Noura R., 38 Jumeirah
Verified
Rating: 3.5 out of 5

I had trouble remembering the midday dose during work. Writing each dose in my phone helped. I did not notice a major problem after that, although the first few days included mild nausea.

2 Oct 2026
Salma, 45 Mussafah
Verified
Rating: 3 out of 5

The medicine did not suit me. I developed a spreading rash and stopped trying to manage it myself after contacting a clinician. The treatment was changed, and the rash settled.

14 Oct 2026
Get our free app Shop faster and track your orders 3.8 · 441 reviews Install